U.S. flag An official website of the United States government.
Official websites use .gov

A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS

A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

i

Cellular f-actin levels as a marker for cellular transformation: correlation with bladder cancer risk



Details

  • Personal Author:
  • Description:
    A risk stratification scheme was used to investigate the possibility of using quantitative F-actin measurements in urinary cells to provide diagnostic or prognostic information by identifying those individuals with cells tending towards a lower degree of differentiation. Bladder wash samples were taken from 163 symptomatic patients undergoing evaluation for bladder cancer and 41 asymptomatic comparisons with no hematuria or other symptoms consistent with bladder cancer. Flow cytometry using a fluorescent phallodin probe was used to evaluate F-actin levels. The risk of bladder cancer was stratified according to biopsy, either DNA ploidy by flow cytometry or quantitative fluorescence image analysis cytology, previous bladder cancer history, and hematuria. A strong correlation was noted between the presence of cells with abnormally low F-actin content in cells obtained by bladder wash from 38 patients and biopsy proved bladder transitional cell carcinoma. The presence of cells with low F-actin content was also highly correlated to risk of bladder cancer assessed by either stratification schema. Because of the 37% false positive rate of ploidy analysis by flow cytometry among the comparison patients, the correlation was more consistent with the stratification by quantitative fluorescence image analysis cytology. The F-actin content of the M344-positive cells was lower than that of the M344- negative cells. These findings suggested that F-actin could be an early and sensitive marker for bladder cancer detection and risk prognostication. [Description provided by NIOSH]
  • Subjects:
  • Keywords:
  • ISSN:
    0008-5472
  • Document Type:
  • Funding:
  • Genre:
  • Place as Subject:
  • CIO:
  • Topic:
  • Location:
  • Volume:
    51
  • Issue:
    11
  • NIOSHTIC Number:
    nn:00214023
  • Citation:
    Cancer Res 1991 Jun; 51(11):2762-2767
  • Contact Point Address:
    Urology University of Oklahoma Dept of Urology, PO Box 26901 Oklahoma City, OK 73190
  • Federal Fiscal Year:
    1991
  • Performing Organization:
    University of Oklahoma Hlth Sciences Ctr, Oklahoma City, Oklahoma
  • Peer Reviewed:
    True
  • Start Date:
    19890930
  • Source Full Name:
    Cancer Research
  • End Date:
    19990430
  • Collection(s):
  • Main Document Checksum:
    urn:sha-512:fb03016dd80920bc6c35b391c9609916265fee59b3ae1812c65a7506484cc7ac7b00f1081ba6e5c5de41312cd308f65dc112bb024d85b8a1af30572c379864af
  • Download URL:
  • File Type:
    Filetype[PDF - 1.40 MB ]
ON THIS PAGE

CDC STACKS serves as an archival repository of CDC-published products including scientific findings, journal articles, guidelines, recommendations, or other public health information authored or co-authored by CDC or funded partners.

As a repository, CDC STACKS retains documents in their original published format to ensure public access to scientific information.